相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Single photon emission computed tomography/computed tomography in the evaluation of neuroendocrine tumours: a review of the literature
Suat-Jin Lu et al.
NUCLEAR MEDICINE COMMUNICATIONS (2013)
Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia
Vera Froeling et al.
ANNALS OF NUCLEAR MEDICINE (2012)
Cost comparison of In-111-DTPA-octreotide scintigraphy and Ga-68-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours
Nils F. Schreiter et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET
Valentina Ambrosini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours
Levent Kabasakal et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Are contrast media required for (68)Ga-DOTATOC PET/CT in patients with neuroendocrine tumours of the abdomen?
Marius E. Mayerhoefer et al.
EUROPEAN RADIOLOGY (2012)
Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours
Nils F. Schreiter et al.
EUROPEAN RADIOLOGY (2012)
Prospective evaluation of 68Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma: preliminary results from a single centre study
Niraj Naswa et al.
EUROPEAN RADIOLOGY (2012)
High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours
Michael S. Hofman et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2012)
Clinical PET of Neuroendocrine Tumors Using 64Cu-DOTATATE: First-in-Humans Study
Andreas Pfeifer et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
The Role of 68Ga-DOTATATE PET/CT in Suspected Neuroendocrine Tumors
Alexander R. Haug et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
ENETS 2011 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: An Update
Ramon Salazar et al.
NEUROENDOCRINOLOGY (2012)
Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis
Giorgio Treglia et al.
ENDOCRINE (2012)
Gallium-68-DOTA-NOC PET/CT of Patients With Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Single-Center Study
Niraj Naswa et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny F. Whiting et al.
ANNALS OF INTERNAL MEDICINE (2011)
Role of 68Ga-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumours
Rakesh Kumar et al.
EUROPEAN RADIOLOGY (2011)
68Ga-DOTATOC PET/CT of Neuroendocrine Tumors: Spotlight on the CT Phases of a Triple-Phase Protocol
Juri Ruf et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
68Ga-DOTATOC Versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors
Thorsten D. Poeppel et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
68Ga-DOTA-NOC PET/CT Imaging of Neuroendocrine Tumors: Comparison with 111In-DTPA-Octreotide (OctreoScan®)
Yodphat Krausz et al.
MOLECULAR IMAGING AND BIOLOGY (2011)
The Impact of 68Ga-DOTATOC Positron Emission Tomography/Computed Tomography on the Multimodal Management of Patients With Neuroendocrine Tumors
Andrea Frilling et al.
ANNALS OF SURGERY (2010)
Ga-68 DOTATOC PET, Endoscopic Ultrasonography, and Multidetector CT in the Diagnosis of Duodenopancreatic Neuroendocrine Tumors A Single-Centre Retrospective Study
Annibale Versari et al.
CLINICAL NUCLEAR MEDICINE (2010)
A review on the clinical uses of SPECT/CT
Giuliano Mariani et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE
Irene Virgolini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors
Valentina Ambrosini et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
The Role of Ga-68-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on In-111-DTPA-Octreotide Scintigraphy
Rajaventhan Srirajaskanthan et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine Tumor
Aaron I. Vinik et al.
PANCREAS (2010)
Role of68Ga-DOTATOC PET/CT in the Evaluation of Primary Pulmonary Carcinoids
Tarun Jindal et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2010)
Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours
Alexander Haug et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
A Comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in Pulmonary Neuroendocrine Tumors
Irfan Kayani et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Bone Metastases in Patients with Neuroendocrine Tumor: 68Ga-DOTA-Tyr3-Octreotide PET in Comparison to CT and Bone Scintigraphy
Daniel Putzer et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Functional Imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (Dota-DPhe1,Tyr3-octreotate) and 18F-FDG
Irfan Kayani et al.
CANCER (2008)
Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours
Valentina Ambrosini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography
Klaas P. Koopmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours
I. Buchmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors:: Comparison with somatostatin receptor scintigraphy and CT
Michael Gabriel et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Nuclear imaging of neuroendocrine tumours
Anders Sundin et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews
Beverley J. Shea et al.
BMC MEDICAL RESEARCH METHODOLOGY (2007)
Imaging of neuroendocrine tumors
Vittoria Rufini et al.
SEMINARS IN NUCLEAR MEDICINE (2006)
Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
S Koukouraki et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC:: preliminary data
M Hofmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)
分享论文
